Arbutus Biopharma
ABUS
#7051
Rank
โ‚ฌ0.56 B
Marketcap
3,66ย โ‚ฌ
Share price
-1.23%
Change (1 day)
-2.08%
Change (1 year)

Earnings for Arbutus Biopharma (ABUS)

Earnings in 2026 (TTM): โ‚ฌ0.13 Billion

According to Arbutus Biopharma 's latest financial reports the company's current earnings are โ‚ฌ0.18 Billion. In 2025 the company made an earning of -โ‚ฌ30.54 Million, an increase over its 2024 earnings that were of -โ‚ฌ63.74 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Arbutus Biopharma from 2008 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) โ‚ฌ0.13 B-533.26%
2025 -โ‚ฌ30.54 Million-52.09%
2024 -โ‚ฌ63.74 Million-4.02%
2023 -โ‚ฌ66.41 Million12.05%
2022 -โ‚ฌ59.27 Million-14.74%
2021 -โ‚ฌ69.51 Million19.61%
2020 -โ‚ฌ58.11 Million-61.69%
2019 -โ‚ฌ0.16 Billion171.23%
2018 -โ‚ฌ55.92 Million-43.58%
2017 -โ‚ฌ99.13 Million-77.77%
2016 -โ‚ฌ0.45 Billion532.77%
2015 -โ‚ฌ70.48 Million99.05%
2014 -โ‚ฌ35.41 Million175.82%
2013 -โ‚ฌ12.84 Million-143.7%
2012 โ‚ฌ29.37 M-399.11%
2011 -โ‚ฌ9.83 Million-39.03%
2010 -โ‚ฌ16.11 Million100.55%
2009 -โ‚ฌ8.04 Million-28.56%
2008 -โ‚ฌ11.25 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Nymox Pharmaceutical
NYMX
-โ‚ฌ1.97 Million-101.41% Bahamas
NRC Health
NRC
โ‚ฌ13.48 M-90.34%๐Ÿ‡บ๐Ÿ‡ธ USA